CA968801A - Salicylate derivative - Google Patents

Salicylate derivative

Info

Publication number
CA968801A
CA968801A CA118,029A CA118029A CA968801A CA 968801 A CA968801 A CA 968801A CA 118029 A CA118029 A CA 118029A CA 968801 A CA968801 A CA 968801A
Authority
CA
Canada
Prior art keywords
salicylate derivative
salicylate
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA118,029A
Other languages
English (en)
Other versions
CA118029S (fr
Inventor
Edward Henderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA968801A publication Critical patent/CA968801A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/86—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA118,029A 1970-07-15 1971-07-13 Salicylate derivative Expired CA968801A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5526970A 1970-07-15 1970-07-15

Publications (1)

Publication Number Publication Date
CA968801A true CA968801A (en) 1975-06-03

Family

ID=21996783

Family Applications (1)

Application Number Title Priority Date Filing Date
CA118,029A Expired CA968801A (en) 1970-07-15 1971-07-13 Salicylate derivative

Country Status (11)

Country Link
US (1) US3703519A (fr)
AU (1) AU3120871A (fr)
BE (1) BE769981A (fr)
CA (1) CA968801A (fr)
DE (1) DE2135523A1 (fr)
DK (1) DK125468B (fr)
FR (1) FR2104788B1 (fr)
GB (1) GB1351853A (fr)
NL (1) NL7109752A (fr)
SE (1) SE359836B (fr)
ZA (1) ZA714606B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505862A (en) * 1981-04-14 1985-03-19 Bristol-Myers Company Diphenydramine dihydrogencitrate
US4401665A (en) * 1981-04-14 1983-08-30 Bristol-Myers Company Sleep-aid composition containing an analgesic and diphenhydramine dihydrogencitrate, and method of use
US5961732A (en) * 1997-06-11 1999-10-05 Fsi International, Inc Treating substrates by producing and controlling a cryogenic aerosol
US8470805B2 (en) * 2009-04-30 2013-06-25 Kaohsiung Medical University Processes for preparing piperazinium salts of KMUP and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE543570A (fr) *
DE591808C (de) * 1931-04-24 1934-01-27 Chem Fab Tempelhof Akt Ges Verfahren zur Herstellung einer fuer Injektionen geeigneten Loesung von salicylsaurem Piperazin

Also Published As

Publication number Publication date
ZA714606B (en) 1972-07-26
NL7109752A (fr) 1972-01-18
DE2135523A1 (de) 1972-01-20
BE769981A (fr) 1971-11-16
GB1351853A (en) 1974-05-01
FR2104788A1 (fr) 1972-04-21
US3703519A (en) 1972-11-21
FR2104788B1 (fr) 1975-03-14
SE359836B (fr) 1973-09-10
AU3120871A (en) 1973-01-18
DK125468B (da) 1973-02-26

Similar Documents

Publication Publication Date Title
AU451793B2 (en) Pyridoquinoline derivatives
AU453008B2 (en) Triazolobenzodiazepine derivatives
AU466630B2 (en) Ergolene derivatives
CA968801A (en) Salicylate derivative
CA1014574A (en) Phenylisopropylamine derivatives
CA948206A (en) Indenopyrrole derivatives
CA951727A (en) Triazolobenzodiazepine derivatives
CA966833A (en) Phenanthrotriazolyl derivatives
AU3306971A (en) Leucauramine derivatives
AU446117B2 (en) Dihydropyrimidopyridazine derivatives
CA963005A (en) Benzodazepine derivatives
AU2648271A (en) 2-amino-imidazol-2-ine derivatives
CA831519A (en) Lignane derivative
AU448194B2 (en) Dibenzothiopene derivatives
AU439043B2 (en) Puridazone derivatives
AU462056B2 (en) Indenopyrrole derivatives
AU456187B2 (en) Benzocycloheptaisoquinoline derivatives
AU453581B2 (en) Indenopyridine derivatives
CA834197A (en) 6-phenylbenzazolyl derivatives
CA835400A (en) Indenopyridine derivatives
CA837137A (en) Penta-chlorobenzylidenamine derivatives
AU444748B2 (en) Aryloxyalkylmorpholine derivatives
AU448291B2 (en) Bornanamine derivatives
CA838131A (en) Benzepine derivatives
CA837631A (en) Sulfonamidoindole derivatives